Cerenome (CNSY) Director Ronald Andrews Converts 921 RSUs

What Happened
Ronald Andrews, a director of Cerenome, had 921 restricted stock units (RSUs) convert to common stock on October 1, 2026 (reported as a derivative exercise/conversion). The filing shows 921 shares acquired at $0.00 and a matching 921-share derivative disposition at $0.00; no cash consideration or dollar value is reported on the form.

Key Details

• Transaction date: 2026-10-01. Report filed 2026-10-01 (no late filing indicated).
• Reported entries: 921 shares acquired via exercise/conversion (code M) at $0.00; 921 shares disposed (code M) at $0.00.
• Shares owned after the transactions: not specified in the provided filing.
• Footnotes: F1 — each RSU converts to one share of common stock; F2 — the RSU grant vests in four substantially equal quarterly installments beginning July 1, 2026 (this appears to be one installment).
• The filing does not specify reasons for the matching disposition (e.g., tax withholding or transfer).

Context
This appears to be a routine RSU vesting/conversion event rather than an open-market buy or sell. Matching dispositions in filings like this are commonly used to cover tax withholding or administrative transfers, but the form here does not state the reason. Such compensation-related conversions are common and do not necessarily indicate the director's view on the company’s stock.